Findings

What do systematic reviews say?

7 questions · 7 findings · 3 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%

T‐cell antibody induction vs corticosteroid induction

Mortality Mortality at latest · liver transplant recipients

T‐cell antibody induction showed no clear difference in mortality Mortality at latest compared with corticosteroid induction (low certainty).

1 finding from 1 review

Antibody induction versus corticosteroid induction for liver transplant recipients 2014 · Cochrane Headline outcomes only
RR 1.01 [0.72, 1.43]
10 studies · 1589 participants
Low

T‐cell antibody induction vs placebo or no intervention

Mortality Mortality at latest · liver transplant recipients

T‐cell antibody induction may leads to lower mortality Mortality at latest compared with placebo/no intervention (low certainty).

1 finding from 1 review

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients 2014 · Cochrane Headline outcomes only
RR 0.91
16 studies · 1853 participants
Low

Monoclonal antibody vs polyclonal antibody

Mortality Mortality at latest · heart transplant recipients

Monoclonal antibody showed no clear difference in mortality Mortality at latest compared with polyclonal antibody (low certainty).

1 finding from 1 review

Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
RR 1 [0.9, 1.1]
7 studies · 315 participants
Low

Interleukin‐2 RA induction vs monoclonal antibody induction

Mortality Mortality at latest · heart transplant recipients

Interleukin‐2 RA induction showed no clear difference in mortality Mortality at latest compared with monoclonal antibody induction (low certainty).

1 finding from 1 review

Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
RR 0.8 [0.19, 3.41]
2 studies · 159 participants
Low

Interleukin‐2 RA vs polyclonal antibody induction

Mortality Mortality at latest · heart transplant recipients

Interleukin‐2 RA showed no clear difference in mortality Mortality at latest compared with polyclonal antibody induction (low certainty).

1 finding from 1 review

Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
RR 1.1 [0.65, 1.88]
4 studies · 185 participants
Low

Intervention not reported

Mortality Mortality at latest · heart transplant recipients

The intervention showed no clear difference in mortality Mortality at latest (low certainty).

1 finding from 1 review

Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
RR 1.53 [0.85, 2.76]
5 studies · 606 participants
Low

Interleukin‐2 RA vs no induction

Mortality Mortality at latest · heart transplant recipients

Interleukin‐2 RA showed no clear difference in mortality Mortality at latest compared with no induction (low certainty).

1 finding from 1 review

Immunosuppressive T‐cell antibody induction for heart transplant recipients 2013 · Cochrane Headline outcomes only
RR 1.53 [0.85, 2.76]
4 studies · 576 participants
Low